Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 906866 | ISIN: US0231351067 | Ticker-Symbol: AMZ
Tradegate
15.01.25
11:10 Uhr
211,25 Euro
-0,15
-0,07 %
1-Jahres-Chart
AMAZON.COM INC Chart 1 Jahr
5-Tage-Chart
AMAZON.COM INC 5-Tage-Chart
RealtimeGeldBriefZeit
211,20211,2511:10
211,25211,3011:11
PR Newswire
379 Leser
Artikel bewerten:
(2)

Embr Labs, Recognized as Leading Menopause innovator by Femtech World, Launches on Amazon in the UK

Finanznachrichten News

BOSTON, Aug. 14, 2024 /PRNewswire/ -- Embr Labs, Inc, makers of Embr Wave®, the leading temperature wearable, today announced the availability of its award-winning product on Amazon in the United Kingdom. Now, consumers are able to buy the Embr Wave from the largest e-commerce retailer in the UK. The news follows last quarter's announcement that Embr Labs was honored for menopause innovation by Femtech World, the UK's leading platform for cutting edge femtech news and research.

(PRNewsfoto/Embr Labs)

Embr Labs' mission is to help women live better lives through personal temperature control that alleviates the most impactful symptoms of menopause. The Embr Wave and its cutting edge cooling technology delivers a new category of natural solutions to manage hot flashes, sleep issues, stress, and thermal discomfort. With the Embr Wave now available for purchase on Amazon UK, even more women have access to this life-improving, even life-changing, wearable technology than ever before.

"We receive ongoing and frequent requests from UK consumers to obtain the Embr Wave, so making the product available with Amazon was a natural step for the company", said Sam Shames, Co-Founder and COO of Embr Labs. Embr Wave is also available for purchase in the UK from Boots and No7 e-commerce sites, and QVC UK.

"We were delighted to be recognized by the UK's Femtech World as the category winner for Menopause Innovation as we enter the UK market", said Heather Ritchie, Chief Strategy Officer of Embr Labs. "The UK has been leading the global discussion around menopause, so to receive recognition from Femtech World in the UK was a true honor for the company." Companies were recognized across several areas - from fertility to pregnancy and cancer innovation.

In addition to opening up new geographical markets, Embr Labs recently announced the availability of its award-winning product via a monthly $20 subscription that is currently available in the US. Consumers in the US now have two options to buy: the Embr Wave can be purchased outright, or customers can subscribe to the Embrship, where the device is provided free of charge along with a comprehensive membership package that offers additional, ongoing benefits including a lifetime warranty and free upgrade options. Embr Labs has plans to bring its subscription option, known as the Embrship, to every market it serves.

About Embr Labs, Inc.

Embr Labs is the leading healthtech company addressing health conditions through temperature. The company's technology delivers a new category of natural solutions to manage hot flashes, sleep issues, stress, and thermal discomfort. The company was founded at MIT and is backed by Bose Ventures, DigiTx Partners, Safar Partners, Esplanade Ventures, and Ghost Tree Partners. Embr Labs has won numerous awards, including the AARP Innovation in Aging Award, Time Magazine's Best Inventions, the iF Design Award, and was named to CB Insights' Digital Health 150.

CONTACT: Sam Shames: sam@embrlabs.com

Logo - https://mma.prnewswire.com/media/2208914/4858156/Embr_Labs_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/embr-labs-recognized-as-leading-menopause-innovator-by-femtech-world-launches-on-amazon-in-the-uk-302221344.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.